Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LAGE-1a is an isoform of the L antigen family member 1, also known as cancer/testis antigen 2 (CTAG2). It belongs to the ESO/LAGE family of cancer-testis antigens (CTAs), characterized by restricted expression in normal tissues (primarily testis) but aberrant activation in various cancers. It is expressed in various tumors including melanoma, lung carcinoma and is being explored as an immunotherapeutic target.
Immunotherapy target; peptide vaccines or adoptive cell therapies targeting CTAs
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on L antigen family member 1 isoform A (LAGE-1a).